New Report Highlights How Drug Companies Fail To Protect Women
Here's a timely, intriguing report. It's titled: THE BITTEREST PILL – How Drug Companies Fail To Protect Women and How Lawsuits Save Their Lives, and it's by Amanda Melpolder, Amy Widman and Joanne Doroshow from the Center for Justice and Democracy. I just received it so I haven't read the whole report yet. But here's a link to the report, a link to the executive summary , and a link to the press release.
Here's an excerpt from the executive summary:
Women across the country have suffered tremendously as a result of defective and dangerous drugs and medical devices. History shows that many FDA-approved drugs and devices that have caused some of the most serious injuries and death have been marketed specifically for women... Many drugs and devices were made safer only after women and their families filed lawsuits against those responsible. Sometimes, companies that have been hit with large verdicts or settlements act immediately to change their unsafe product or practice. Lawsuits also have had a tremendously beneficial role spurring medical research and alerting the public – and ultimately pressuring regulators – to act on larger health risks and problems. As a result, the lives of countless other women have been saved.
The report is timely because next week isn't just big because of the election: on Monday, the Supreme Court will hear Wyeth v. Levine, which we've blogged about many times before on TortDeform (see here). The Supreme Court's ruling on this case will effect our ability to fight for safe products and corporate responsibility. It's important that we pay close attention to cases like this, even during the election frenzy (into which I've very much been swept).
So check out the report!
Kia Franklin: Author Bio | Other Posts
Posted at 4:30 PM, Oct 29, 2008 in Consumer Rights | FDA | Federal Preemption | Pharmaceuticals | Preemption | Product Liability | Reports | Supreme Court Rulings | Tort "Reform" & Gender | Under-regulation
Permalink | Email to Friend | Comments (2)